Clinical Trial Update: Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 trial update showing results on efficacy, mechanisms and safety of SGLT2 inhibitors in kidney transplant recipients; the study includes participants wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttransplant Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitors (class)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Kidney Transplant Recipients, Post-transplant Diabetes Mellitus | Phase 3 | Status: COMPLETED